Evidence map›Paper›PMID 31066440›Full record

ArticleJournal of Crohn's & colitis2019

Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.

Marjolein A Y Klaassen, Floris Imhann, Valerie Collij, Jingyuan Fu, Cisca Wijmenga, Alexandra Zhernakova, Gerard Dijkstra, Eleonora A M Festen, Ranko Gacesa, Arnau Vich Vila and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Marjolein A Y KlaassenUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Floris ImhannUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Valerie CollijUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Jingyuan FuUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Cisca WijmengaUniversity Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Alexandra ZhernakovaUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Gerard DijkstraUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Eleonora A M FestenUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Ranko GacesaUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Arnau Vich VilaUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
Rinse K WeersmaUniversity Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsCrohn's disease [CD] is a chronic inflammatory disorder of the gastrointestinal tract characterised by alternating periods of exacerbation and remission. We hypothesised that changes in the gut microbiome are associated with CD exacerbations, and therefore aimed to correlate multiple gut microbiome features to CD disease activity.

methodsFaecal microbiome data generated using whole-genome metagenomic shotgun sequencing of 196 CD patients were of obtained from the 1000IBD cohort [one sample per patient]. Patient disease activity status at time of sampling was determined by re-assessing clinical records 3 years after faecal sample production. Faecal samples were designated as taken 'in an exacerbation' or 'in remission'. Samples taken 'in remission' were further categorised as 'before the next exacerbation' or 'after the last exacerbation', based on the exacerbation closest in time to the faecal production date. CD activity was correlated with gut microbial composition and predicted functional pathways via logistic regressions using MaAsLin software.

resultsIn total, 105 bacterial pathways were decreased during CD exacerbation (false-discovery rate [FDR] <0.1) in comparison with the gut microbiome of patients both before and after an exacerbation. Most of these decreased pathways exert anti-inflammatory properties facilitating the biosynthesis and fermentation of various amino acids [tryptophan, methionine, and arginine], vitamins [riboflavin and thiamine], and short-chain fatty acids [SCFAs].

conclusionsCD exacerbations are associated with a decrease in microbial genes involved in the biosynthesis of the anti-inflammatory mediators riboflavin, thiamine, and folate, and SCFAs, suggesting that increasing the intestinal abundances of these mediators might provide new treatment opportunities. These results were generated using bioinformatic analyses of cross-sectional data and need to be replicated using time-series and wet lab experiments.

Indexed as

Gastrointestinal MicrobiomeAdultBacteriaCohort StudiesCrohn DiseaseDNA, BacterialFatty Acids, VolatileFecesFemaleFolic AcidHumansMalePrincipal Component AnalysisRiboflavinThiamineWhole Genome SequencingDNA, BacterialFatty Acids, VolatileFolic AcidRiboflavinThiamineCrohn’s disease activityfaecal microbiomewhole-genome metagenomic shotgun sequencing

Identifiers

PMID31066440
PMCPMC7142399
OpenAlexW2937171139

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.